-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The cumulative amount of the reporting entity's undistributed earnings or deficit.
-
Summary
-
NewAmsterdam Pharma Co N.V. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from Q4 2022 to Q2 2024.
- NewAmsterdam Pharma Co N.V. Retained Earnings (Accumulated Deficit) for the quarter ending June 30, 2024 was -$450M.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)